CURE Vision: Pediatric Cancer Research
We imagine a future where every child’s cancer journey is met with kinder treatments, fewer late effects, and care that protects their joy.
What we focus on
Kinder therapies
Early-stage ideas that lower toxicity, reduce late effects, and protect childhood along the way.
Rare & overlooked
Seed funding for sarcomas and other underfunded pediatric cancers that struggle to get early data.
Quality of life
Studies that ease pain, anxiety, and isolation—so kids and siblings feel seen during treatment.
AI-driven discovery
Use AI to speed insights, targeting safer, faster treatments for kids.
Roadmap
- H1 2026: Build a scientific advisory circle and formalize review criteria that center safety, feasibility, and equity.
- H2 2026: Launch the Kyra Gupta Research Grant to help researchers generate pilot data for larger trials or institutional backing.
- 2027+: Grow into co-funding partnerships with hospitals and labs, prioritizing trials that improve day-to-day quality of life.
Our commitments
- Families first: We prioritize studies that measurably improve a child’s daily experience.
- Collaboration: Partner with clinicians, child life teams, and researchers to keep care humane and hopeful.
- Focus on the overlooked: Start with Ewing Sarcoma and other underfunded pediatric cancers.
- Collaboration: Partner with clinicians, child-life teams, and researchers to keep care humane and hopeful.
Connect with us
If you are a researcher, clinician, or partner exploring a study that aligns with this vision, email us via the Contact page. We'll share timelines, criteria, and how to co-create the next grant cycle.